Clinical Trial Update: A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of MEN2312 for advanced breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MEN2312

Snippet

Sponsor: Stemline Therapeutics, Inc. | Conditions: Advanced Breast Cancer | Phase 1 | Status: RECRUITING